Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001193125-25-288529

Chief Operating Officer sold 125,589 shares at an average $16.17 ($2,030,923)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bensen Daniel Chief Operating Officer 2025-11-18 Sale 10b5-1 −75,633 $16.07 $1,215,627 220,937 D: show line 1 in the form
Bensen Daniel Chief Operating Officer 2025-11-19 Sale 10b5-1 −49,956 $16.32 $815,297 170,981 D: show line 2 in the form
Open-market sales · 125,589 sh · avg $16.17 · $2,030,923
Loading xslF345X05/ownership.xml…